Firestone Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-355
Closed -$18K 246
2021
Q3
$18K Hold
355
0.01% 318
2021
Q2
$18K Buy
355
+4
+1% +$192 0.01% 310
2021
Q1
$16K Buy
351
+3
+0.9% +$136 0.01% 320
2020
Q4
$16K Buy
348
+3
+0.9% +$138 0.01% 319
2020
Q3
$16K Buy
345
+3
+0.9% +$150 0.01% 278
2020
Q2
$17K Buy
342
+108
+46% +$5.54K 0.01% 275
2020
Q1
$11K Buy
234
+2
+0.9% +$107 0.01% 299
2019
Q4
$14K Buy
+232
New +$12.9K 0.01% 323

Other funds holding GSK

Firestone Capital Management's GSK Position: Q4 2021 in Review

Firestone Capital Management sold out of GSK (GSK) in Q4 2021, closing a stake of 355 shares — an estimated $18K sold.

Firestone Capital Management first reported a position in GSK in Q4 2019 and held it in 8 quarters. The position peaked at $18K in Q3 2021. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Firestone Capital Management reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Firestone Capital Management sold 355 GSK shares in Q4 2021, an estimated $18K.
  • Firestone Capital Management first reported a position in GSK in Q4 2019 and held it in 8 quarters.
  • Firestone Capital Management's GSK position peaked at $18K in Q3 2021.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Firestone Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.